Balaxi Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹63.77Cr
Net Profits
₹6.48Cr
Net Profit Margins
10.16%

Highlights

Revenue:

Balaxi Pharmaceuticals Ltd’s revenue fell -1.82% since last year same period to ₹63.77Cr in the Q1 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 7.83% jump in its revenue since last 3-months.

Net Profits:

Balaxi Pharmaceuticals Ltd’s net profit jumped 115.67% since last year same period to ₹6.48Cr in the Q1 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -40.71% fall in its net profits since last 3-months.

Net Profit Margins:

Balaxi Pharmaceuticals Ltd’s net profit margin jumped 115.96% since last year same period to 10.16% in the Q1 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -45.02% fall in its net profit margins since last 3-months.

FAQs

The revenue for Balaxi Pharmaceuticals Ltd in the Q1 results 2024 was ₹63.77Cr.

The net profit for Balaxi Pharmaceuticals Ltd in the Q1 results 2024 was ₹6.48Cr.

The net profit margin for Balaxi Pharmaceuticals Ltd in the Q1 results 2024 was 10.16%.

The revenue for Balaxi Pharmaceuticals Ltd in the Q1 results 2023 was ₹64.95Cr.

The net profit for Balaxi Pharmaceuticals Ltd in the Q1 results 2023 was ₹-41.34Cr.

The net profit margin for Balaxi Pharmaceuticals Ltd in the Q1 results 2023 was -63.65%.